This increased expression of SAR1A is specific to KLHL40-deficient skeletal muscle as analysis of skeletal muscle from centronuclear myopathy patients (RYR1 or MTM1 disease-causing mutations) showed no changes in the SAR1A protein levels compared to the control (Figure 9—figure supplement 1). This evidence concerns the gene SAR1A and autosomal dominant centronuclear myopathy.